Cinctive Capital Management LP Abb Vie Inc. Call Options Transaction History

Cinctive Capital Management LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $4.13 Million - $5.25 Million	-30,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $29 Million - $36 Million	-220,000 Reduced 88.0%	30,000 $4.86 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $26.6 Million - $30.2 Million	250,000 New	250,000 $27 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.